F5 (0IL6)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 459.79 |
|---|---|
| 52-week range | 224.25 – 488.42 |
| Return, 1 month / 3 months | +2.7% / +14.8% |
| Return, 1 year / 3 years | +54.9% / +206.3% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 34.6% |
| Worst drawdown (1 year) | -12.9% |
| Average daily value traded | 0.17M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
F5 is a technology company based in Seattle that provides application delivery networking and security products. Its main offerings include load balancing and traffic management appliances, application security and firewall tools, and software for managing how applications are delivered across data centres and cloud environments. It serves enterprises, service providers and government organisations, helping them keep applications available, fast and protected. The company also offers related support and subscription services for its hardware and software products.
F5 trades under the code 0IL6 on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
F5 (0IL6) trades on the London Stock Exchange in UK. It last closed at USD 459.79 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 276 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.9% and over the last three months it rose 14.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.6% | ||
| From 52-week high | -4.4% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.8% | ||
| 6-month return | 54.4% | ||
| 12-month return, skipping the last month | 50.8% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.9% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.17M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +2.7% |
| 3 months | +14.8% |
| 6 months | +54.4% |
| 1 year | +54.9% |
| 3 years | +206.3% |
| 5 years | +110.9% |
Signals
| 50-day / 200-day average | 430.68 / 363.16 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 18.72 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.